AHCC News

SIRveNIB abstract published by ASCO, to be presented on 4 June 

Click here to read.

American Society of Clinical Oncology (ASCO) Publishes Abstract of SIRveNIB, an Investigator-led Asia Pacific Primary Liver Cancer Study to be Presented at ASCO Annual Meeting in Chicago, 4 June 2017 

Click here to read.

American Society of Clinical Oncology (ASCO) Publishes Abstract of SIRveNIB, an Investigator-led Asia Pacific Primary Liver Cancer Study to be Presented at ASCO Annual Meeting in Chicago, 4 June 2017 

Click here to read.

American Society of Clinical Oncology (ASCO) Publishes Abstract of SIRveNIB, an Investigator-led Asia Pacific Primary Liver Cancer Study to be Presented at ASCO Annual Meeting in Chicago, 4 June 2017 

Click here to read.

Doctors a step closer to giving liver cancer patients a more precise treatment 

Click here to read.

Chance for personalised treatment if liver cancer strikes again 

Click here to read.

Liver cancer difficult to treat due to huge tumour variations 

Click here to read.

SIRveNIB, a major primary liver cancer study in the Asia-Pacific region, completes enrolment 

Click here to read.

SIRveNIB, a Major Primary Liver Cancer Study in the Asia-Pacific Region, Completes Enrolment 

Click here to read.

SIRveNIB, a Major Primary Liver Cancer Study in the Asia-Pacific Region, Completes Enrolment 

Click here to read.

SIRveNIB, a Major Primary Liver Cancer Study in the Asia-Pacific Region, Completes Enrolment 

Click here to read.

Singapore to be only nation with liver cancer registry in Asia 

Click here to read.

$7.5 million to be pumped into liver cancer research 

Click here to read.

The Award of a $7.5 million Translational Clinical Research Grant from National Medical Research Council Launches the Flagship Programme in Liver Cancer 

Click here to read.

Regional liver cancer registry to be set up 

Click here to read.

National Cancer Centre Singapore signs MOUs for liver cancer research collaborations 

Click here to read.

First in Asia to Develop Liver Cancer Registry Through Collaborations Among National Cancer Centre Singapore, Singapore Clinical Research Institute and IMS Health 

Click here to read.

AHCC Trials Group unveils new information for liver cancer treatment 

Click here to read.

Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group initiates Collaborative partnership in hope to develop new HCC therapies 

Click here to read.
National Cancer Centre Singapore

Interim analysis found SGH-led SIRveNIB regional phase III clinical trial to treat patients with locally advanced liver cancer right on track 

Click here to read.
Singapore General Hospital

New wonder treatment for liver cancer (Wijeya Newspapers Ltd, Colombo, Sri Lanka)

Click here to read.
Singapore General Hospital

防肝癌 也需防 脂肪肝(LianHe WanBao)

Click here to read. 
Singapore General Hospital

New Cancer Treatment Gives New Lease of Life (The Straits Times)

Click here to read. 
Singapore General Hospital

体内放射疗法 可治多种肝癌 (LianHe WanBao)

Click here to read. 
Singapore General Hospital

Novel combination of two existing therapeutics shows promising activity in patients with advanced liver cancer 

An Interview with Prof Pierce Chow and Dr Choo Su Pin on AHCC05 Study: Phase I/II Study of SIR-Spheres plus Sorafenib (Chemo-Radiotherapy) as first line treatment in patients with non-resectable primary hepatocellular carcinoma. 

By Medical Grapevine >> Read the AHCC05 article

Record Funding for Liver Cancer Drugs Test (The Straits Times)

Click here to read.  
Singapore General Hospital

Life span of inoperable advanced liver cancer patients may be extended by 9 months or more with combined treatment. 

Click here to read. 
National Cancer Centre Singapore

New Trials give Hope to Liver Cancer Patients (The Straits Times)

Click here to read. 
Singapore General Hospital

Singapore benefits in economic and social spin-offs from medical scientific community playing key role in mega clinical trials 

Click here to read.
National Cancer Centre Singapore